Found 9 results
Name | Type of Offering | Accepted Date |
---|---|---|
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2011-03-10 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-11-002088
Exclusions or Exemptions
N/A
Accepted Date
2011-03-10
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2015-03-12 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-15-002837
Exclusions or Exemptions
506b
Accepted Date
2015-03-12
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2012-03-12 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-12-002166
Exclusions or Exemptions
N/A
Accepted Date
2012-03-12
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2016-03-14 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-16-011860
Exclusions or Exemptions
506b
Accepted Date
2016-03-14
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D | 2010-03-10 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-10-002234
Exclusions or Exemptions
N/A
Accepted Date
2010-03-10
Type of Offering
D
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2013-03-12 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-13-002271
Exclusions or Exemptions
N/A
Accepted Date
2013-03-12
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2014-03-12 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-14-002223
Exclusions or Exemptions
506b
Accepted Date
2014-03-12
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Pooled Investment Fund
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2017-03-13 15:56:53 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-17-002741
Exclusions or Exemptions
506b
Accepted Date
2017-03-13 15:56:53
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
First Eagle Value in Biotechnology Fund (QP), LP
See All Filings
|
D/A | 2018-03-13 14:39:16 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001481559
Filed Document
0000919574-18-002434
Exclusions or Exemptions
506b
Accepted Date
2018-03-13 14:39:16
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|